Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 74

The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.

Shifting equilibriums in Alzheimer’s disease: the complex roles of microglia in neuroinflammation, neuronal survival and neurogenesis

Gray, Sophie C., Kinghorn, Kerri J., Woodling, Nathaniel S. · 2020 · Neural Regeneration Research

Abstract

Alzheimer’s disease is the leading cause of dementia. Its increased prevalence in developed countries, due to the sharp rise in ageing populations, presents one of the costliest challenges to modern medicine. In order to find disease-modifying therapies to confront this challenge, a more complete understanding of the pathogenesis of Alzheimer’s disease is necessary. Recent studies have revealed increasing evidence for the roles played by microglia, the resident innate immune system cells of the brain. Reflecting the well-established roles of microglia in reacting to pathogens and inflammatory stimuli, there is now a growing literature describing both protective and detrimental effects for individual cytokines and chemokines produced by microglia in Alzheimer’s disease. A smaller but increasing number of studies have also addressed the divergent roles played by microglial neurotrophic and neurogenic factors, and how their perturbation may play a key role in the pathogenesis of Alzheimer’s disease. Here we review recent findings on the roles played by microglia in neuroinflammation, neuronal survival and neurogenesis in Alzheimer’s disease. In each case, landmark studies have provided evidence for the divergent ways in which microglia can either promote neuronal function and survival, or perturb neuronal function, leading to cell death. In many cases, the secreted molecules of microglia can lead to divergent effects depending on the magnitude and context of microglial activation. This suggests that microglial functions must be maintained in a fine equilibrium, in order to support healthy neuronal function, and that the cellular microenvironment in the Alzheimer’s disease brain disrupts this fine balance, leading to neurodegeneration. Thus, an understanding of microglial homeostasis, both in health and across the trajectory of the disease state, will improve our understanding of the pathogenic mechanisms underlying Alzheimer’s disease, and will hopefully lead to the development of microglial-based therapeutic strategies to restore equilibrium in the Alzheimer’s disease brain.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.4103/1673-5374.272571

Cites

55 of 55 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 59

  1. Appel, 2018, Increased microglial activity, impaired adult hippocampal neurogenesis, and depressive-like behavior in microglial VPS35-depleted mice, J Neurosci, 38, 5949, 10.1523/JNEUROSCI.3621-17.2018 · DOI
  2. Augustin, 2018, Impact of insulin signaling and proteasomal activity on physiological output of a neuronal circuit in aging Drosophila melanogaster, Neurobiol Aging, 66, 149, 10.1016/j.neurobiolaging.2018.02.027 · DOI
  3. Augustin, 2017, Reduced insulin signaling maintains electrical transmission in a neural circuit in aging flies, PLoS Biol, 15, e2001655, 10.1371/journal.pbio.2001655 · DOI
  4. Bachstetter, 2015, Disease-related microglia heterogeneity in the hippocampus of Alzheimer’s disease, dementia with Lewy bodies, and hippocampal sclerosis of aging, Acta Neuropathol Commun, 3, 32, 10.1186/s40478-015-0209-z · DOI · Paper page
  5. Barclay, 2002, CD200 and membrane protein interactions in the control of myeloid cells, Trends Immunol, 23, 285, 10.1016/S1471-4906(02)02223-8 · DOI · Paper page
  6. Boekhoorn, 2006, Increased proliferation reflects glial and vascular-associated changes, but not neurogenesis in the presenile Alzheimer hippocampus, Neurobiol Dis, 24, 1, 10.1016/j.nbd.2006.04.017 · DOI · Paper page
  7. Braak, 1995, Staging of Alzheimer’s disease-related neurofibrillary changes, Neurobiol Aging, 16, 271, 10.1016/0197-4580(95)00021-6 · DOI · Paper page
  8. Cacci, 2008, In vitro neuronal and glial differentiation from embryonic or adult neural precursor cells are differently affected by chronic or acute activation of microglia, Glia, 425, 412, 10.1002/glia.20616 · DOI · Paper page
  9. Cavanagh, 2018, Preventing synaptic deficits in Alzheimer’s disease by inhibiting tumor necrosis factor alpha signaling, IBRO Rep, 4, 18, 10.1016/j.ibror.2018.01.003 · DOI
  10. Choi, 2008, Non-cell-autonomous effects of presenilin 1 variants on enrichment-mediated hippocampal progenitor cell proliferation and differentiation, Neuron, 59, 568, 10.1016/j.neuron.2008.07.033 · DOI · Paper page
  11. Clayton, 2017, Alzheimer’s disease: the role of microglia in brain homeostasis and proteopathy, Front Neurosci, 11, 1, 10.3389/fnins.2017.00680 · DOI
  12. Cohen, 2009, Reduced IGF-1 signaling delays age-associated proteotoxicity in mice, Cell, 139, 1157, 10.1016/j.cell.2009.11.014 · DOI · Paper page
  13. Corder, 1993, Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families, Science, 261, 921, 10.1126/science.8346443 · DOI · Paper page
  14. Crocker, 2002, Siglecs: sialic-acid-binding immunoglobulin-like lectins in cell–cell interactions and signalling, Curr Opin Struct Biol, 12, 609, 10.1016/S0959-440X(02)00375-5 · DOI · Paper page
  15. Dos Santos, 2017, Validating GWAS variants from microglial genes implicated in Alzheimer’s disease, J Mol Neurosci, 62, 215, 10.1007/s12031-017-0928-7 · DOI
  16. Encinas, 2011, Division-coupled astrocytic differentiation and age-related depletion of neural stem cells in the adult hippocampus, Cell Stem Cell, 8, 566, 10.1016/j.stem.2011.03.010 · DOI · Paper page
  17. Eriksson, 1998, Neurogenesis in the adult human hippocampus, Nat Med, 4, 1313, 10.1038/3305 · DOI · Paper page
  18. Fan, 2017, Dysregulation of neurogenesis by neuroinflammation: key differences in neurodevelopmental and neurological disorders, Neural Regen Res, 12, 366, 10.4103/1673-5374.202926 · DOI
  19. Femminella, 2019, Microglial activation in early Alzheimer trajectory is associated with higher gray matter volume, Neurology, 92, 1331, 10.1212/WNL.0000000000007133 · DOI
  20. Ferreira, 2018, Variants in Alzheimer’s disease, J Mol Neurosci, 64, 471
  21. Ginhoux, 2010, Fate mapping analysis reveals that adult microglia derive from primitive macrophages, Science, 330, 841, 10.1126/science.1194637 · DOI · Paper page
  22. Gomes-Leal, 2019, Why microglia kill neurons after neural disorders? The friendly fire hypothesis, Neural Regen Res, 14, 1499, 10.4103/1673-5374.255359 · DOI
  23. Hickman, 2013, The microglial sensome revealed by direct RNA sequencing, Nat Neurosci, 16, 1896, 10.1038/nn.3554 · DOI · Paper page
  24. Hoek, 2000, Down-regulation of the macrophage lineage through interaction with OX2 ( CD200), Science, 290, 1768, 10.1126/science.290.5497.1768 · DOI · Paper page
  25. Kandimalla, 2017, Is Alzheimer’s disease a type 3 diabetes? A critical appraisal, Biochim Biophys Acta Mol Basis Dis, 1863, 1078, 10.1016/j.bbadis.2016.08.018 · DOI · Paper page
  26. Keren-Shaul, 2017, A unique microglia type associated with restricting development of Alzheimer’s disease, Cell, 169, 1276, 10.1016/j.cell.2017.05.018 · DOI · Paper page
  27. Kuhn, 2015, Control of cell survival in adult mammalian neurogenesis, Cold Spring Harb Perspect Biol, 10.1101/cshperspect.a018895 · DOI
  28. Kwilasz, 2015, The therapeutic potential of interleukin-10 in neuroimmune diseases, Neuropharmacology, 96, 55, 10.1016/j.neuropharm.2014.10.020 · DOI · Paper page
  29. Labandeira-Garcia, 2017, Insulin-like growth factor-1 and neuroinflammation, Front Aging Neurosci, 9, 365, 10.3389/fnagi.2017.00365 · DOI · Paper page
  30. Landreth, 2009, Toll-like receptors in Alzheimer’s disease, Curr Top Microbiol Immunol, 336, 137
  31. Li, 2015, CD33 rs3865444 polymorphism contributes to Alzheimer’s disease susceptibility in Chinese, European, and North American populations, Mol Neurobiol, 52, 414, 10.1007/s12035-014-8880-9 · DOI
  32. Mandrekar, 2010, Microglia and inflammation in Alzheimer’s disease, CNS Neurol Disord Drug Targets, 9, 156, 10.2174/187152710791012071 · DOI · Paper page
  33. Mir, 2017, IGF-1 mediated neurogenesis involves a novel RIT1/Akt/Sox2 cascade, Sci Rep, 7, 3283, 10.1038/s41598-017-03641-9 · DOI
  34. Montgomery, 2011, Ablation of TNF-RI/RII expression in Alzheimer’s disease mice leads to an unexpected enhancement of pathology: implications for chronic pan-TNF-α suppressive therapeutic strategies in the brain, Am J Pathol, 179, 2053, 10.1016/j.ajpath.2011.07.001 · DOI · Paper page
  35. Myhre, 2019, Microglia express insulin-like growth factor-1 in the hippocampus of aged APPswe/PS1dE9 transgenic mice, Front Cell Neurosci, 13, 308, 10.3389/fncel.2019.00308 · DOI
  36. Nikolakopoulou, 2013, Activated microglia enhance neurogenesis via trypsinogen secretion, Proc Natl Acad Sci U S A, 110, 8714, 10.1073/pnas.1218856110 · DOI
  37. Nimmerjahn, 2005, Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo, Science, 308, 1314, 10.1126/science.1110647 · DOI · Paper page
  38. Park, 2017, The Alzheimer’s disease-associated R47H variant of TREM2 has an altered glycosylation pattern and protein stability, Front Neurosci, 10, 618, 10.3389/fnins.2016.00618 · DOI
  39. Pluchino, 2008, Persistent inflammation alters the function of the endogenous brain stem cell compartment, Brain, 131, 2564, 10.1093/brain/awn198 · DOI · Paper page
  40. Qian, 2008, Potent anti-inflammatory and neuroprotective effects of TGF-beta1 are mediated through the inhibition of ERK and p47phox-Ser345 phosphorylation and translocation in microglia, J Immunol, 181, 660, 10.4049/jimmunol.181.1.660 · DOI
  41. Satoh, 2018, Gene expression profiles of M1 and M2 microglia characterized by Public Datasets, Clin Exp Neuroimmunol, 9, 124, 10.1111/cen3.12426 · DOI
  42. Sheng, 2001, Interleukin-1 promotion of MAPK-p38 overexpression in experimental animals and in Alzheimer’s disease: potential significance for tau protein phosphorylation, Neurochem Int, 39, 341, 10.1016/S0197-0186(01)00041-9 · DOI · Paper page
  43. Sorrells, 2018, Human hippocampal neurogenesis drops sharply in children to undetectable levels in adults, Nature, 555, 377, 10.1038/nature25975 · DOI · Paper page
  44. Steculorum, 2014, The paradox of neuronal insulin action and resistance in the development of aging-associated diseases, Alzheimers Dement, 10, S3, 10.1016/j.jalz.2013.12.008 · DOI
  45. Tan, 2013, NLRP3 polymorphisms are associated with late-onset Alzheimer’s disease in Han Chinese, J Neuroimmunol, 265, 91, 10.1016/j.jneuroim.2013.10.002 · DOI
  46. Tang, 2016, Differential roles of M1 and M2 microglia in neurodegenerative diseases, Mol Neurobiol, 53, 1181, 10.1007/s12035-014-9070-5 · DOI · Paper page
  47. Taylor, 2017, TGF- β1 modulates microglial phenotype and promotes recovery after intracerebral hemorrhage, J Clin Invest, 127, 280, 10.1172/JCI88647 · DOI · Paper page
  48. Tepavčević, 2011, Inflammation-induced subventricular zone dysfunction leads to olfactory deficits in a targeted mouse model of multiple sclerosis, J Clin Invest, 121, 4722, 10.1172/JCI59145 · DOI
  49. Tong, 2016, Role of microglia in embryonic neurogenesis, Exp Biol Med (Maywood), 241, 1669, 10.1177/1535370216664430 · DOI
  50. Verkhratsky, 2013, Astroglia in neurological diseases, Futur Neurol, 8, 149, 10.2217/fnl.12.90 · DOI · Paper page
  51. Wachs, 2006, Transforming growth factor-beta1 is a negative modulator of adult neurogenesis, J Neuropathol Exp Neurol, 65, 358, 10.1097/01.jnen.0000218444.53405.f0 · DOI · Paper page
  52. Walton, 2006, Microglia instruct subventricular zone neurogenesis, Glia, 54, 815, 10.1002/glia.20419 · DOI · Paper page
  53. Wang, 2015, TREM2 lipid sensing sustains microglia response in an Alzheimer’s disease model, Cell, 160, 1061, 10.1016/j.cell.2015.01.049 · DOI · Paper page
  54. Wine, 2009, IGF-1 and pAKT signaling promote hippocampal CA1 neuronal survival following injury to dentate granule cells, Neurotox Res, 16, 280, 10.1007/s12640-009-9060-y · DOI
  55. Yuan, 2016, TREM2 haplodeficiency in mice and humans impairs the microglia barrier function leading to decreased amyloid compaction and severe axonal dystrophy, Neuron, 90, 724, 10.1016/j.neuron.2016.05.003 · DOI · Paper page
  56. Zheng, 2017, TREM2 promotes microglial survival by activating Wnt/β-catenin pathway, J Neurosci, 37, 1772, 10.1523/JNEUROSCI.2459-16.2017 · DOI · Paper page
  57. Zheng, 2010, NMDA-induced neuronal survival is mediated through nuclear factor I-A in mice, J Clin Invest, 120, 2446, 10.1172/JCI33144 · DOI
  58. Zhong, 2018, Amyloid-beta modulates microglial responses by binding to the triggering receptor expressed on myeloid cells 2 (TREM2), Mol Neurodegener, 13, 15, 10.1186/s13024-018-0247-7 · DOI · Paper page
  59. Zuroff, 2017, Clearance of cerebral Aβ in Alzheimer’s disease: reassessing the role of microglia and monocytes, Cell Mol Life Sci, 74, 2167, 10.1007/s00018-017-2463-7 · DOI · Paper page

Cited by

See all 74

Metadata

Authors
Gray, S. C., Kinghorn, K. J., & Woodling, N. S.
Affiliations
Institute of Healthy Ageing and Department of Genetics, Evolution and Environment, University College London, London, UK
Venue
Neural Regeneration Research
Published
2020-01-09
Volume
15
Issue
7
Pages
1208-1219
ISSN
  • 1673-5374
  • 1876-7958
Cited by
74
References
55
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.